News Archives - Page 10 of 11 - SOHO Insider

Skip to content

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL
SOHO EAGLE program takes off, expanding access to education globally
Dr. Shulman discusses US cancer surveillance challenges
New blood test diagnoses multiple myeloma noninvasively
Treatment post-relapse improves survival outcomes in patients with AML or MDS

Join SOHO

Follow Us :

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL

Cellular Therapy

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL

Leukemia

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL

Lymphoma

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL

Multiple Myeloma

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL

Myelodysplastic Syndromes

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

August 19, 2025

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library News

Circulating tumor DNA

Lymphoma Aggressive B-Cell Lymphomas News

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL

by SOHO Insider Editors
January 9, 2025
0 Comments

Elias Jabbour, MD, University of Texas MD Anderson Cancer Center

66th American Society of Hematology Annual Meeting & Exposition Leukemia News Video Interviews

Elias Jabbour, MD, talks about obe-cel ASH updates, FDA approval

by SOHO Insider Editors
December 20, 2024
0 Comments

European Medicines Agency (EMA)

Myelodysplastic Syndromes News

CHMP announces positive opinion for imetelstat in lower-risk MDS treatment

by SOHO Insider Editors
December 19, 2024
0 Comments

Peihua Lu, MD, Beijing hematologist oncologist

Meetings / Conferences 66th American Society of Hematology Annual Meeting & Exposition Lymphoma News Video Interviews

Dr. Lu discusses CD7-targeted CAR-T cell therapy at ASH 2024

by Leah Sherwood
December 13, 2024
0 Comments

Sagar Lonial Introduces SOHO Insider

Multiple Myeloma News

Introducing SOHO Insider

by Leah Sherwood
December 12, 2024
0 Comments

press release

News Society Updates

SOHO Launches SOHO Insider for hemonc news

by SOHO Insider Editors
December 8, 2024
0 Comments

Dna,Gene,Helix,Spiral,Molecule,Structure

Leukemia News

FDA approves revumenib for relapsed or refractory acute leukemia with a KMT2A translocation

by sohonews
November 21, 2024
0 Comments

Leukemia cells and red blood cells

Leukemia Chronic Myeloid Leukemia News

Dasatinib, asciminib combo shows ‘promise’ for upfront treatment of Ph+ ALL

by SOHO Insider Editors
November 15, 2024
0 Comments

Myelodysplastic Syndromes News

FDA approves luspatercept in adult patients with low-risk MDS

by sohonews
November 14, 2024
0 Comments

Lymphoma Indolent B-Cell Lymphomas News

Epcoritamab shows ‘clinically meaningful activity’ in EPCORE NHL primary analysis

by sohonews
November 14, 2024
0 Comments

1
...
8
9
10
11

Top Categories

Cellular Therapy

13

Leukemia

44

Lymphoma

50

Multiple Myeloma

42

Myelodysplastic Syndromes

16

Myeloproliferative Neoplasms

11

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Categories

Epcoritamab shows ‘clinically meaningful activity’ in EPCORE NHL primary analysis

Cellular Therapy

Epcoritamab shows ‘clinically meaningful activity’ in EPCORE NHL primary analysis

Leukemia

Epcoritamab shows ‘clinically meaningful activity’ in EPCORE NHL primary analysis

Lymphoma

Epcoritamab shows ‘clinically meaningful activity’ in EPCORE NHL primary analysis

Multiple Myeloma

Epcoritamab shows ‘clinically meaningful activity’ in EPCORE NHL primary analysis

Myelodysplastic Syndromes

Epcoritamab shows ‘clinically meaningful activity’ in EPCORE NHL primary analysis

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Submit

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL

SOHO EAGLE program takes off, expanding access to education globally

Dr. Shulman discusses US cancer surveillance challenges

Copyright © 2025 Society of Hematologic Oncology, All rights reserved.